NABI » Topics » Option/SAR Grants in Last Fiscal Year

This excerpt taken from the NABI DEF 14A filed Apr 7, 2006.

Option/SAR Grants in Last Fiscal Year

 

The following table contains information concerning individual grants of stock options made during the Company’s last completed fiscal year to each of the Named Executive Officers. To date, the Company has not granted stock appreciation rights.

 

Name


 

Number of
Securities
Underlying

Options

Granted (#)(1)


   

Percent of

Total Options

Granted To

Employees in

Fiscal Year


   

Exercise

Price ($/sh)


 

Expiration

Date


 

Potential Realizable

Value at Assumed

Annual Rates of Stock

Price Appreciation for
Option Terms


          5%($)

  10%($)

Thomas H. McLain

  150,000     7.58 %   $ 12.06   03/14/2015   1,137,670   2,883,080

Raafat E.F. Fahim, Ph.D.

  0     0 %   $ 0   N/A   0   0

H. LeRoux Jooste

  0     0 %   $ 0   N/A   0   0

Henrik S. Rasmussen, M.D., Ph.D.

  0     0 %   $ 0   N/A   0   0

Mark L. Smith

  75,000 (2)   3.79 %   $ 12.06   03/14/2015   568,835   1,441,540

(1)   These options become exercisable in four equal annual installments beginning one year from the date of grant. The Compensation Committee may at any time accelerate the exercisability of any option. In addition, in the event of a change in control of the Company, the Compensation Committee may take such actions with respect to the options as it considers equitable and in the best interests of the Company. Under the terms of his employment agreement, if Mr. McLain is terminated without cause (as defined in his agreement), then each of his non-vested options will immediately vest and be exercisable for one year following his termination date, but in no event later than the original option expiration date. Under the terms of his change of control agreement, if Mr. McLain is terminated in connection with a change of control (as defined in his agreement), then each of his non-vested options will immediately vest and be exercisable for specified periods, but in no event later than the original option expiration date.

 

(2)   As a result of Mr. Smith’s resignation, these options will expire on June 4, 2006.

 

9


"Option/SAR Grants in Last Fiscal Year" elsewhere:

Medarex (MEDX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki